COVID-19 vaccines Vaccine safety data Main navigation COVID-19 vaccines Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5-11 years) Pfizer bivalent COVID-19 vaccine Moderna COVID-19 vaccine Moderna bivalent COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine AusVaxSafety is conducting active vaccine safety surveillance of the COVID-19 vaccines in use in Australia to ensure their ongoing safety. The COVID-19 vaccines currently being used are Comirnaty (Pfizer), Vaxzevria (AstraZeneca), Spikevax (Moderna) and Nuvaxovid (Novavax). AusVaxSafety is currently reporting safety data on Pfizer, AstraZeneca, Moderna and Novavax COVID-19 vaccines. Data on this page will be updated fortnightly. Latest fortnightly COVID-19 vaccine safety data Click on the tiles below to view AusVaxSafety COVID-19 vaccine safety data for specific population groups. Pfizer COVID-19 vaccine adult formulation View the latest safety data for Pfizer COVID-19 vaccine adult formulation here Pfizer COVID-19 vaccine paediatric formulation (5-11 years) View the latest safety data for Pfizer COVID-19 vaccine paediatric formulation (5-11 years) here Pfizer bivalent COVID-19 vaccine View the latest Pfizer bivalent COVID-19 vaccine safety data here Moderna COVID-19 vaccine View the latest Moderna COVID-19 vaccine safety data here Moderna bivalent COVID-19 vaccine View the latest Moderna bivalent COVID-19 vaccine safety data here Novavax COVID-19 vaccine View the latest Novavax COVID-19 vaccine safety data here AstraZeneca COVID-19 vaccine View the latest AstraZeneca COVID-19 vaccine safety data here Vaccine safety data Main navigation COVID-19 vaccines Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5-11 years) Pfizer bivalent COVID-19 vaccine Moderna COVID-19 vaccine Moderna bivalent COVID-19 vaccine Novavax COVID-19 vaccine AstraZeneca COVID-19 vaccine Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox) vaccine News & events All news & events 17 May 2023 | News Subcutaneous and intradermal administration of mpox vaccine well tolerated, AusVaxSafety study finds 10 May 2023 | News New bivalent BA.4/BA.5 COVID-19 booster vaccines well tolerated by Australians, new AusVaxSafety data show 20 April 2023 | News Influenza is back in Australia in 2023: Why a flu shot is so important, who is eligible and what to expect in the days following your vaccination 04 April 2023 | News AusVaxSafety commences routine surveillance of 2023 seasonal flu vaccines